Evaluation of pseudoprogression rates and tumor progression patterns in a phase III trial of bevacizumab plus radiotherapy/temozolomide for newly diagnosed glioblastoma
Wick, Wolfgang, Chinot, Olivier L., Bendszus, Martin, Mason, Warren, Henriksson, Roger, Saran, Frank, Nishikawa, Ryo, Revil, Cedric, Kerloeguen, Yannick, Cloughesy, TimothyLanguage:
english
Journal:
Neuro-Oncology
DOI:
10.1093/neuonc/now091
Date:
August, 2016
File:
PDF, 321 KB
english, 2016